|
Parameter
|
Standard deviation of repeated measures
|
Coefficient of variation (%)
|
|---|
|
Total SSc population
|
Cohort 1 (SSc without PAH)
|
Cohort 2 (SSc with PAH)
|
Total SSc population
|
Cohort 1 (SSc without PAH)
|
Cohort 2 (SSc with PAH)
|
|---|
|
TAPSE, cm
|
0.02
|
0.01
|
0.02
|
0.9
|
0.6
|
1.1
|
|
FAC, %
|
11.2
|
9.1
|
13.4
|
21.3
|
17.0
|
27.1
|
|
Tissue Doppler S’
|
0.4
|
0.3
|
0.5
|
3.2
|
2.5
|
4.2
|
|
RVOT VTI, cm
|
0.8
|
1.0
|
0.7
|
6.0
|
7.0
|
5.0
|
|
Global RVLSS, %
|
1.9
|
2.6
|
1.1
|
9.7
|
11.7
|
6.6
|
|
RVSP, mmHg
|
14.3
|
5.3
|
24.2
|
38.0
|
19.6
|
48.6
|
|
TAPSE:PASP, mm/mmHg
|
0.01
|
0.02
|
0.003
|
1.7
|
2.2
|
0.6
|
- Abbreviations: SSc systemic sclerosis, PAH pulmonary arterial hypertension, TAPSE tricuspid annular plane systolic excursion, FAC fractional area change, S’ Tissue Doppler-derived right ventricular systolic excursion velocity, RVOT right ventricular outflow tract, VTI velocity time integral, RVLSS right ventricular longitudinal systolic strain, RVSP right ventricular systolic pressure, PASP pulmonary artery systolic pressure
